The drug was approved to treat patients who have already received chemotherapy under an accelerated approval process after a ...

The FDA has granted accelerated approval to datopotamab deruxtecan (Datroway) for adults with locally advanced or metastatic non-small cell lung cancer that carries an EGFR mutation and has progressed ...

The Innovation Center of NanoMedicine has summarized the results of its collaborative research with Professor Kanjiro ...

A South Korean research team has accomplished what was once thought of as science fiction: reprogramming malignant cancer ...

A gene-editing delivery system developed by UT Southwestern Medical Center researchers simultaneously targeted the liver and ...

Figure 1.An Overview of the Current Status of DLL3-Targeted Drug Development for SCLC Treatment. This figure illustrates the current landscape of DLL3-targeted therapies for small-cell lung cancer ...

The BioNTech SE acquisition of CureVac N.V. brings together complementary technologies, as both are developing mRNA ...

Scientists have made a key breakthrough for treating respiratory diseases by developing a new drug delivery system that transports genetic therapies ...

We could be on the verge of a major cancer treatment breakthrough, with a new vaccine shown to completely obliterate pancreatic cancer cells in preclinical trials. This paves the way for it to move ...

A scientific team has unlocked a new way to treat serious lung conditions by using specially designed nanoparticles to ...

Lung cancer is one of the most frequently diagnosed cancers and the leading cause of cancer-related deaths worldwide with an estimated 2 million new cases and 1·76 million deaths per year. Substantial ...

Jazz Pharmaceuticals (JAZZ) stock gains as its lung cancer therapy Zepzelca, in combination with Roche's Tecentriq, receives FDA priority review. Read more here.